- Abstract:
-
Striant SR (marketed as Striant in the US) is a novel sustained-release mucoadhesive buccal testosterone tablet for the treatment of male hypogonadism. Striant SR restores serum testosterone concentrations to the physiological range within 4 h of application, and steady-state concentrations are achieved within 24 h of twice-daily dosing. In phase III clinical trials, 87-97% of patients using Striant SR achieved 24-h-averaged serum testosterone concentrations within the normal range. In a comp...
Expand abstract - Publication status:
- Published
- Journal:
- International journal of clinical practice
- Volume:
- 58
- Issue:
- 11
- Pages:
- 1073-1080
- Publication date:
- 2004-11-05
- DOI:
- EISSN:
-
1742-1241
- ISSN:
-
1368-5031
- URN:
-
uuid:bfe57dca-f48d-47d4-8c65-09a749dad9f4
- Source identifiers:
-
138377
- Local pid:
- pubs:138377
- Language:
- English
- Keywords:
- Copyright date:
- 2004
Journal article
Striant SR: a novel, effective and convenient testosterone therapy for male hypogonadism.
Actions
Authors
Bibliographic Details
Item Description
Terms of use
Metrics
Altmetrics
Dimensions
If you are the owner of this record, you can report an update to it here: Report update to this record